Temozolomide regresses a doxorubicin‐resistant undifferentiated spindle‐cell sarcoma patient‐derived orthotopic xenograft (PDOX): precision‐oncology nude‐mouse model matching the patient with effective therapy-Reference-Cited by-同舟云学术

Temozolomide regresses a doxorubicin‐resistant undifferentiated spindle‐cell sarcoma patient‐derived orthotopic xenograft (PDOX): precision‐oncology nude‐mouse model matching the patient with effective therapy

Published:2018-05-08 Issue:8 Volume:119 Page:6598-6603
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J. Cell. Biochem.

Author:

Igarashi Kentaro¹²³,Kawaguchi Kei¹²,Kiyuna Tasuku¹²,Miyake Kentaro¹²,Miyake Masuyo¹²,Li Yunfeng⁴,Nelson Scott D.⁴,Dry Sarah M.⁴,Singh Arun S.⁵,Elliott Irmina A.⁶,Russell Tara A.⁶,Eckardt Mark A.⁷,Yamamoto Norio³,Hayashi Katsuhiro³,Kimura Hiroaki³,Miwa Shinji³,Tsuchiya Hiroyuki³,Eilber Fritz C.⁶,Hoffman Robert M.¹²^ORCID

Affiliation:

1. AntiCancerInc.San DiegoCalifornia

2. Department of SurgeryUniversity of CaliforniaSan DiegoCalifornia

3. Department of Orthopaedic SurgeryKanazawa UniversityKanazawaJapan

4. Department of PathologyUniversity of CaliforniaLos AngelesCalifornia

5. Division of Hematology‐OncologyUniversity of CaliforniaLos AngelesCalifornia

6. Division of Surgical OncologyUniversity of CaliforniaLos AngelesCalifornia

7. Department of SurgeryYale School of MedicineNew HavenConnecticut

Funder

Division of Cancer Prevention, National Cancer Institute

Publisher

Wiley